I sent this email to Dr. Janet Woodcock this morni
Post# of 148183
(Total Views: 1435)
Posted On: 10/25/2020 4:21:01 PM
I sent this email to Dr. Janet Woodcock this morning -
Subject: OWS Help with Leronlimab Supply
Dear Dr. Woodcock,
I know your time is extremely valuable in these pandemic times but I would ask for a minute of that time.
I am sure you have heard of Leronlimab, a monoclonal antibody made by Cytodyn Inc. What you may not be aware of is that data is now available for the asking on its efficacy and safety from a Phase 3 DSMC Interim Review.
Because of the special mandate of OWS to find and accelerate delivery of effective treatments for SARS2, I truly feel that if your eyes were to fall on this Interim Data that you would see that Leronlimab is perhaps the best therapeutic you are likely to find!
Although tested outside of the framework of the ACTIV program, the data, generated with the rigors of the normal FDA standard, don't lie.
I am totally confident of Leronlimab's eventual approval for treatment of SARS2. I feel that it will be a blockbuster in that regard. So that is not what I want to bring to your attention.
What concerns me is that Cytodyn is a very small company and its supply capabilities are very limited. I watched your interview with Meg Terrill on CNBC and heard you confirm that it was very hard to approve a drug if supply of the drug is lacking.
Therefore, I am asking you, in your present capacity at OWS, to help accelerate the manufacture and supply of Leronlimab, the therapeutic that could take the spectre of dying from SARS2 off the table.
Please request the Phase 3 Interim Data from Cytodyn and look at it as soon as possible. Leronlimab, I believe, is totally worthy of your attention and won't let us down.
The contact information for Cytodyn is -
Cytodyn Inc.
1111 Main Street
Suite 660
Vancouver, WA 98660
Tel: 360-980-8524
Fax: 360-799-5954
Email
info@cytodyn.com
CEO
Nader Z. Pourhassan, Ph.D.
Phone
360-980-8524 ext. 101
Email
npourhassan@cytodyn.com
I truly appreciate the work that you and all public health professionals are doing to protect us from this horrible virus and other threats to our public health. You have my deepest gratitude! Best of luck to you all.
Sincerely yours,
XXXX XXXXX
XXXXXXXXX@aol.com
XXX-XXX-XXXX
Salem, Oregon
FYI, I am a shareholder in Cytodyn.
Subject: OWS Help with Leronlimab Supply
Dear Dr. Woodcock,
I know your time is extremely valuable in these pandemic times but I would ask for a minute of that time.
I am sure you have heard of Leronlimab, a monoclonal antibody made by Cytodyn Inc. What you may not be aware of is that data is now available for the asking on its efficacy and safety from a Phase 3 DSMC Interim Review.
Because of the special mandate of OWS to find and accelerate delivery of effective treatments for SARS2, I truly feel that if your eyes were to fall on this Interim Data that you would see that Leronlimab is perhaps the best therapeutic you are likely to find!
Although tested outside of the framework of the ACTIV program, the data, generated with the rigors of the normal FDA standard, don't lie.
I am totally confident of Leronlimab's eventual approval for treatment of SARS2. I feel that it will be a blockbuster in that regard. So that is not what I want to bring to your attention.
What concerns me is that Cytodyn is a very small company and its supply capabilities are very limited. I watched your interview with Meg Terrill on CNBC and heard you confirm that it was very hard to approve a drug if supply of the drug is lacking.
Therefore, I am asking you, in your present capacity at OWS, to help accelerate the manufacture and supply of Leronlimab, the therapeutic that could take the spectre of dying from SARS2 off the table.
Please request the Phase 3 Interim Data from Cytodyn and look at it as soon as possible. Leronlimab, I believe, is totally worthy of your attention and won't let us down.
The contact information for Cytodyn is -
Cytodyn Inc.
1111 Main Street
Suite 660
Vancouver, WA 98660
Tel: 360-980-8524
Fax: 360-799-5954
info@cytodyn.com
CEO
Nader Z. Pourhassan, Ph.D.
Phone
360-980-8524 ext. 101
npourhassan@cytodyn.com
I truly appreciate the work that you and all public health professionals are doing to protect us from this horrible virus and other threats to our public health. You have my deepest gratitude! Best of luck to you all.
Sincerely yours,
XXXX XXXXX
XXXXXXXXX@aol.com
XXX-XXX-XXXX
Salem, Oregon
FYI, I am a shareholder in Cytodyn.
(22)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼